Literature DB >> 17272823

Regulation of Bcl-xL expression in lung vascular smooth muscle.

Yuichiro J Suzuki1, Hiroko Nagase, Chi Ming Wong, Shilpashree Vinod Kumar, Vivek Jain, Ah-Mee Park, Regina M Day.   

Abstract

Pulmonary hypertension is characterized by thickened pulmonary arterial walls due to increased number of pulmonary artery smooth muscle cells (PASMC). Apoptosis of PASMC may play an important role in regulating the PASMC number and may be useful for reducing pulmonary vascular thickening. The present study examined the regulation of an anti-apoptotic protein Bcl-x(L). Bcl-x(L) expression was found to be increased in the pulmonary artery of chronic hypoxia-treated rats with pulmonary vascular remodeling. Adenovirus-mediated gene transfer of Bcl-x(L) indeed showed that this protein has anti-apoptotic activities in PASMC. Treatment of remodeled pulmonary artery with sodium nitroprusside (SNP) reduced Bcl-x(L) expression by targeting the bcl-x(L) promoter. The bcl-x(L) promoter contains two GATA elements, and SNP decreases the GATA-4 DNA-binding activity. Overexpression of GATA-4 attenuated the SNP-mediated suppression of Bcl-x(L) expression, providing direct evidence for the role of GATA-4 in Bcl-x(L) gene transcription. We established that SNP targets the 250 proximal region of the gata4 promoter and suppresses its gene transcription. Thus, inducers of pulmonary hypertension enhance anti-apoptotic Bcl-x(L) gene transcription, which can be suppressed by targeting gata4 gene transcription.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17272823      PMCID: PMC1868666          DOI: 10.1165/rcmb.2006-0359OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  43 in total

1.  A bcl-xS adenovirus selectively induces apoptosis in transformed cells compared to normal mammary cells.

Authors:  V N Sumantran; D S Lee; K M Woods Ignatoski; S P Ethier; M S Wicha
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

Review 2.  One-year continuous inhaled nitric oxide for primary pulmonary hypertension.

Authors:  G Pérez-Peñate; G Julià-Serdà; J M Pulido-Duque; E Górriz-Gómez; P Cabrera-Navarro
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

3.  Role of proteolysis and apoptosis in regression of pulmonary vascular remodeling.

Authors:  D J Riley; S Thakker-Varia; F J Wilson; G J Poiani; C A Tozzi
Journal:  Physiol Res       Date:  2000       Impact factor: 1.881

4.  Endothelin-1 inhibits apoptosis of pulmonary arterial smooth muscle in the neonatal rat.

Authors:  Robert P Jankov; Crystal Kantores; Rosetta Belcastro; Man Yi; A Keith Tanswell
Journal:  Pediatr Res       Date:  2006-07-20       Impact factor: 3.756

5.  Antisense Bcl-x oligonucleotide induces apoptosis and prevents arterial neointimal formation in murine cardiac allografts.

Authors:  J Suzuki; M Isobe; R Morishita; T Nishikawa; J Amano; Y Kaneda
Journal:  Cardiovasc Res       Date:  2000-02       Impact factor: 10.787

Review 6.  Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension.

Authors:  V Hampl; J Herget
Journal:  Physiol Rev       Date:  2000-10       Impact factor: 37.312

7.  Inhaled nitric oxide in persistent pulmonary hypertension of the newborn.

Authors:  J D Roberts; D M Polaner; P Lang; W M Zapol
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

8.  Overexpression of human KCNA5 increases IK V and enhances apoptosis.

Authors:  Elena E Brevnova; Oleksandr Platoshyn; Shen Zhang; Jason X-J Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2004-05-12       Impact factor: 4.249

9.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

10.  Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture.

Authors:  S L Lee; W W Wang; B J Moore; B L Fanburg
Journal:  Circ Res       Date:  1991-05       Impact factor: 17.367

View more
  14 in total

1.  Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells.

Authors:  Young H Lee; Ognoon Mungunsukh; Rebecca L Tutino; Ana P Marquez; Regina M Day
Journal:  J Cell Sci       Date:  2010-04-20       Impact factor: 5.285

2.  Pulmonary hypertension-induced GATA4 activation in the right ventricle.

Authors:  Ah-Mee Park; Chi-Ming Wong; Ludmila Jelinkova; Lingling Liu; Hiroko Nagase; Yuichiro J Suzuki
Journal:  Hypertension       Date:  2010-11-08       Impact factor: 10.190

3.  Cell signaling pathways for the regulation of GATA4 transcription factor: Implications for cell growth and apoptosis.

Authors:  Yuichiro J Suzuki
Journal:  Cell Signal       Date:  2011-03-01       Impact factor: 4.315

4.  A critical role for the protein apoptosis repressor with caspase recruitment domain in hypoxia-induced pulmonary hypertension.

Authors:  Ari L Zaiman; Rachel Damico; Alan Thoms-Chesley; D Clark Files; Priya Kesari; Laura Johnston; Mara Swaim; Shehzin Mozammel; Alan C Myers; Marc Halushka; Hazim El-Haddad; Larissa A Shimoda; Chang-Fu Peng; Paul M Hassoun; Hunter C Champion; Richard N Kitsis; Michael T Crow
Journal:  Circulation       Date:  2011-11-14       Impact factor: 29.690

5.  GATA factors promote ER integrity and β-cell survival and contribute to type 1 diabetes risk.

Authors:  Daniel J Sartori; Christopher J Wilbur; Simon Y Long; Matthew M Rankin; Changhong Li; Jonathan P Bradfield; Hakon Hakonarson; Struan F A Grant; William T Pu; Jake A Kushner
Journal:  Mol Endocrinol       Date:  2013-01-01

6.  Carfilzomib reverses pulmonary arterial hypertension.

Authors:  Xinhong Wang; Yasmine F Ibrahim; Dividutta Das; Makhosazane Zungu-Edmondson; Nataliia V Shults; Yuichiro J Suzuki
Journal:  Cardiovasc Res       Date:  2016-03-06       Impact factor: 10.787

7.  A novel p38 mitogen-activated protein kinase/Elk-1 transcription factor-dependent molecular mechanism underlying abnormal endothelial cell proliferation in plexogenic pulmonary arterial hypertension.

Authors:  Monal Patel; Dan Predescu; Rajive Tandon; Cristina Bardita; Jennifer Pogoriler; Sangeeta Bhorade; Minhua Wang; Suzy Comhair; Anna Ryan Hemnes; Anna Ryan-Hemnes; Jiwang Chen; Roberto Machado; Aliya Husain; Serpil Erzurum; Sanda Predescu
Journal:  J Biol Chem       Date:  2013-07-26       Impact factor: 5.157

8.  Docetaxel Reverses Pulmonary Vascular Remodeling by Decreasing Autophagy and Resolves Right Ventricular Fibrosis.

Authors:  Yasmine F Ibrahim; Nataliia V Shults; Vladyslava Rybka; Yuichiro J Suzuki
Journal:  J Pharmacol Exp Ther       Date:  2017-07-31       Impact factor: 4.030

9.  Apoptosis-based therapy to treat pulmonary arterial hypertension.

Authors:  Yuichiro J Suzuki; Yasmine F Ibrahim; Nataliia V Shults
Journal:  J Rare Dis Res Treat       Date:  2016

10.  Mechanism of the susceptibility of remodeled pulmonary vessels to drug-induced cell killing.

Authors:  Yasmine F Ibrahim; Chi-Ming Wong; Ludmila Pavlickova; Lingling Liu; Lobsang Trasar; Geetanjali Bansal; Yuichiro J Suzuki
Journal:  J Am Heart Assoc       Date:  2014-02-26       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.